Holen Sie sich die Stockscreener-App
2.19
4.29%
0.09
Savara Inc Aktie (SVRA) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc.SVRA - Bluefield Daily Telegraph
Insiders Who Purchased US$783.7k Of Savara Stock May Not Have Expected 12% Tumble - simplywall.st
Savara’s SWOT analysis: biotech firm’s stock poised for growth with aPAP drug - Investing.com
Savara Inc (NASDAQ:SVRA) Stake Reduced by California State Teachers Retirement System - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $482,000 Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Sold by Bank of America Corp DE - Defense World
Ameriprise Financial Inc. Takes Position in Savara Inc (NASDAQ:SVRA) - Defense World
Jane Street Group LLC Decreases Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
savara elects board members and approves proposals at annual meeting - Investing.com Australia
savara elects board members and approves proposals at annual meeting By Investing.com - Investing.com South Africa
Savara Re-elects Board Members at Annual Meeting - TipRanks
Savara Inc (NASDAQ:SVRA) Shares Bought by Squarepoint Ops LLC - Defense World
FDA Requests Additional Data for Savara’s MOLBREEVI Application - MSN
Savara assumed with an Outperform at Oppenheimer - MSN
Nuveen Asset Management LLC Sells 30,766 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc. to Present at Jefferies Global Healthcare Conference on June 4, 2025 - MSN
Millennium Management LLC Grows Stake in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Bought by ProShare Advisors LLC - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc.SVRA - FinancialContent
Insider Buying Alert: Joseph Mccracken Acquires Additional Shares of Savara Inc (SVRA) - GuruFocus
Oppenheimer assumes Savara stock at outperform, sets $5 price target - Investing.com
Oppenheimer assumes Savara stock at outperform, sets $5 price target By Investing.com - Investing.com Canada
Oppenheimer Adjusts Price Target on Savara to $5 From $15, Maintains Outperform Rating - marketscreener.com
Oppenheimer Maintains Optimism for Savara (SVRA) Despite Filing Setback | SVRA Stock News - GuruFocus
Savara director Joseph McCracken buys $20,825 in stock By Investing.com - Investing.com South Africa
Savara director Joseph McCracken buys $20,825 in stock - Investing.com Australia
What is HC Wainwright’s Forecast for Savara FY2026 Earnings? - Defense World
Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
What is HC Wainwright’s Forecast for Savara FY2029 Earnings? - Defense World
Savara Inc. Grants Equity Awards to New Employees - MSN
FDA Denies Langhorne-Based Savara Application for Rare Lung Disease Treatment - BUCKSCO.Today
Did Savara Inc. (SVRA) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire
Savara (NASDAQ:SVRA) Lowered to “Neutral” Rating by HC Wainwright - Defense World
SVRA: Savara Downgraded by HC Wainwright & Co. | SVRA Stock News - GuruFocus
Savara stock rating cut to Neutral by H.C. Wainwright - Investing.com Nigeria
HC Wainwright & Co. Downgrades Savara (SVRA) - MSN
This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
HC Wainwright Downgrades Savara to Neutral From Buy, Adjusts Price Target to $2 From $6 - marketscreener.com
H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setba - GuruFocus
H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setback | SVRA Stock News - GuruFocus
Savara stock price target cut to $2 at Evercore ISI By Investing.com - Investing.com Canada
Savara Inc (NASDAQ:SVRA) Shares Bought by D. E. Shaw & Co. Inc. - Defense World
Guggenheim Reaffirms “Buy” Rating for Savara (NASDAQ:SVRA) - Defense World
Savara (NASDAQ:SVRA) Given New $2.00 Price Target at Evercore ISI - Defense World
Savara (NASDAQ:SVRA) Price Target Lowered to $7.00 at Wells Fargo & Company - Defense World
SVRA ALERT: Levi & Korsinsky Investigates Savara Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN
0.68%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):